BioMarin Pharmaceutical Inc (FRA:BM8)
€ 53.2 -0.50 (-0.93%) Market Cap: 10.07 Bil Enterprise Value: 9.39 Bil PE Ratio: 43.81 PB Ratio: 1.87 GF Score: 82/100

BioMarin Pharmaceutical Inc Annual Shareholders Meeting Transcript

Jun 02, 2026 / 06:30PM GMT
Release Date Price: €46.89 (-4.50%)
Operator

Good afternoon and welcome to the 2026 annual meeting of stockholders of BioMarin Pharmaceutical, Inc. At this time, I would like to turn the conference over to Alexander Hardy, President and Chief Executive Officer of BioMarin. Please go ahead.

Alexander Hardy
BioMarin Pharmaceutical Inc - President, Chief Executive Officer, Director

On behalf of the entire board, officers and employees, I want to welcome you all to the annual meeting of stockholders of BioMarin Pharmaceutical, Inc. Our Board annually considers the appropriate format of our annual meeting, and this year, we decided to hold a virtual annual meeting.

I am Alexander Hardy, President and Chief Executive Officer of BioMarin , and I will be presiding at this meeting. Eric Fleekop, Vice President and Deputy General Counsel of the company, will act as Secretary of this meeting.

Within the virtual meeting platform, you will find a copy of the rules of conduct and procedures for the annual meeting. To conduct an orderly meeting, we ask that participants abide by these rules. Before

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot